• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nebulization of pharmacological solutions with an innovative medical device based on microvaporization.使用基于微蒸发的创新型医疗设备对药理溶液进行雾化。
Heliyon. 2023 Mar 20;9(3):e14673. doi: 10.1016/j.heliyon.2023.e14673. eCollection 2023 Mar.
2
Robustness of aerosol delivery of amikacin liposome inhalation suspension using the eFlow® Technology.使用 eFlow® 技术的硫酸卷曲霉素脂质体吸入混悬剂的气溶胶输送稳健性。
Eur J Pharm Biopharm. 2021 Sep;166:10-18. doi: 10.1016/j.ejpb.2021.05.021. Epub 2021 Jun 1.
3
Surface active drugs significantly alter the drug output rate from medical nebulizers.表面活性剂显著改变了医用雾化器的药物输出速率。
Int J Pharm. 2010 Jan 15;384(1-2):128-36. doi: 10.1016/j.ijpharm.2009.10.012. Epub 2009 Oct 13.
4
Mitigating Fugitive Aerosols During Aerosol Delivery via High-Flow Nasal Cannula Devices.通过高流量鼻导管装置进行气溶胶输送时减轻逃逸气溶胶
Respir Care. 2022 Apr;67(4):404-414. doi: 10.4187/respcare.09589. Epub 2021 Nov 17.
5
Quantitative analysis of liquids from aerosols and microdrops using laser induced breakdown spectroscopy.利用激光诱导击穿光谱法对气溶胶和微滴中的液体进行定量分析。
Anal Chem. 2012 Mar 6;84(5):2239-44. doi: 10.1021/ac202834j. Epub 2012 Feb 10.
6
Indian Guidelines on Nebulization Therapy.印度雾化治疗指南。
Indian J Tuberc. 2022;69 Suppl 1:S1-S191. doi: 10.1016/j.ijtb.2022.06.004. Epub 2022 Jul 11.
7
Erratum: Preparation of Poly(pentafluorophenyl acrylate) Functionalized SiO2 Beads for Protein Purification.勘误:用于蛋白质纯化的聚(丙烯酸五氟苯酯)功能化二氧化硅微珠的制备
J Vis Exp. 2019 Apr 30(146). doi: 10.3791/6328.
8
Efficient Self-Propelling of Small-Scale Condensed Microdrops by Closely Packed ZnO Nanoneedles.紧密排列的氧化锌纳米针实现小尺寸凝聚微滴的高效自推进
J Phys Chem Lett. 2014 Jun 19;5(12):2084-8. doi: 10.1021/jz500798m. Epub 2014 May 30.
9
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
10
Synchrotron radiation microdiffraction of ballistic molten wax microdrops.弹道熔化石蜡微滴的同步辐射微衍射
Rev Sci Instrum. 2008 Aug;79(8):086106. doi: 10.1063/1.2964108.

引用本文的文献

1
AEROfen: protocol for a phase I, open-label, randomised crossover study evaluating the efficiency of nebulised fentanyl in healthy volunteers - comparing facial versus intranasal administration via pharmacometric modelling.AEROfen:一项I期开放标签随机交叉研究的方案,该研究评估雾化芬太尼在健康志愿者中的有效性——通过药代动力学建模比较经面部给药与经鼻给药。
BMJ Open. 2025 Jul 3;15(7):e091125. doi: 10.1136/bmjopen-2024-091125.
2
Characterization of the symmetrical benzimidazole twin drug TL1228: the role as viral entry inhibitor for fighting COVID-19.对称苯并咪唑双联药物 TL1228 的特性:作为抗 COVID-19 的病毒进入抑制剂的作用。
Biol Direct. 2024 Oct 16;19(1):93. doi: 10.1186/s13062-024-00523-9.

本文引用的文献

1
Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5.双特异性抗体BA7208/7125可有效中和包括奥密克戎BA.1至BA.5在内的新冠病毒变种。
Cell Discov. 2023 Jan 7;9(1):3. doi: 10.1038/s41421-022-00509-9.
2
Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.鼻腔接种基于 MVA 的疫苗可诱导 IgA 并保护 hACE2 小鼠的呼吸道免受 SARS-CoV-2 感染。
Proc Natl Acad Sci U S A. 2022 Jun 14;119(24):e2202069119. doi: 10.1073/pnas.2202069119. Epub 2022 Jun 9.
3
Two Different Therapeutic Approaches for SARS-CoV-2 in hiPSCs-Derived Lung Organoids.两种不同的治疗方法用于诱导多能干细胞衍生肺类器官中的 SARS-CoV-2。
Cells. 2022 Apr 5;11(7):1235. doi: 10.3390/cells11071235.
4
An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.一种基于鼻腔内的 OMV 疫苗可诱导针对 SARS-CoV-2 感染的高黏膜和全身保护免疫。
Front Immunol. 2021 Dec 17;12:781280. doi: 10.3389/fimmu.2021.781280. eCollection 2021.
5
Inhalable mRNA vaccines for respiratory diseases: a roadmap.可吸入 mRNA 疫苗用于呼吸道疾病:路线图。
Curr Opin Biotechnol. 2022 Apr;74:104-109. doi: 10.1016/j.copbio.2021.10.017. Epub 2021 Dec 8.
6
Intranasal vaccine: Factors to consider in research and development.鼻腔内疫苗:研发中需要考虑的因素。
Int J Pharm. 2021 Nov 20;609:121180. doi: 10.1016/j.ijpharm.2021.121180. Epub 2021 Oct 9.
7
Peptide Platform as a Powerful Tool in the Fight against COVID-19.肽平台作为抗击新冠疫情的有力工具
Viruses. 2021 Aug 23;13(8):1667. doi: 10.3390/v13081667.
8
A Recent Update on Intranasal Delivery of High Molecular Weight Proteins, Peptides, and Hormones.鼻腔内递呈高分子量蛋白质、肽和激素的最新进展。
Curr Pharm Des. 2021;27(42):4279-4299. doi: 10.2174/1381612827666210820100723.
9
Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations.四价 SARS-CoV-2 中和抗体表现出增强的效力和对逃逸突变的抗性。
J Mol Biol. 2021 Sep 17;433(19):167177. doi: 10.1016/j.jmb.2021.167177. Epub 2021 Jul 28.
10
Mucosal vaccines - fortifying the frontiers.黏膜疫苗——强化前沿。
Nat Rev Immunol. 2022 Apr;22(4):236-250. doi: 10.1038/s41577-021-00583-2. Epub 2021 Jul 26.

使用基于微蒸发的创新型医疗设备对药理溶液进行雾化。

Nebulization of pharmacological solutions with an innovative medical device based on microvaporization.

作者信息

Brandimarte Bruno, Di Rienzo Businco Lino, Cappello Francesco, Fiore Roberto, Bastone Giuseppe, Gualdi Gianfranco, Sollaku Saadi, Casciani Emanuele, Tortorella Federica, Longo Pasquale, Centanini Eleonora, Pavaci Silva, Sangiuolo Federica, Patrizi Maria Patrizia, Miersch Shane, Sidhu Sachdev S, Sacchini Virgilio, Novelli Giuseppe

机构信息

Electronic Measurements Physics Department, Sapienza University, Rome, Italy.

Otorhinolaryngology Department, Institute of Sport Medicine, Sport e Salute, Rome, Italy.

出版信息

Heliyon. 2023 Mar 20;9(3):e14673. doi: 10.1016/j.heliyon.2023.e14673. eCollection 2023 Mar.

DOI:10.1016/j.heliyon.2023.e14673
PMID:37020941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10068108/
Abstract

The currently available nebulization devices have a slow aerosol flow and produce vapor with large microdrops. Improved devices that achieve higher airflow and produce smaller microdrops are needed to improve the clinical care of patients. To address this critical need, we developed a novel system for the molecular vaporization of liquids. This device vaporizes an active pharmacological substance dissolved in water, alcohol, or a mixture of water and alcohol using two energy sources at the same time: high-frequency ultrasound and thermal induction. Application of energy to a solution contained in the device's tank allows, within tens of seconds, for the vaporization of the solution itself, with the generation of a vapor consisting of microdrops of very small diameter (0.2-0.3 μm). In this article, we illustrate the technology used, the main verification tests performed, and the primary fields of application for this device. In particular, the advantages of both the aerosol delivery system and the administration system are highlighted.

摘要

目前可用的雾化装置气溶胶流速缓慢,产生的蒸汽含有大微滴。需要改进的装置来实现更高的气流并产生更小的微滴,以改善患者的临床护理。为满足这一关键需求,我们开发了一种用于液体分子汽化的新型系统。该装置同时使用两种能量源:高频超声和热感应,将溶解在水、酒精或水与酒精混合物中的活性药理物质汽化。对装置储罐中所含溶液施加能量,可在数十秒内使溶液本身汽化,产生由直径非常小(0.2 - 0.3μm)的微滴组成的蒸汽。在本文中,我们阐述了所使用的技术、进行的主要验证测试以及该装置的主要应用领域。特别是,突出了气溶胶输送系统和给药系统的优势。